drugset / Trial / NCT02162849
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
Phase 4
Active not recruiting
204 enrolled
M.D. Anderson Cancer Center
NAL PHARMA · collabPfizer · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this clinical research study is learn if varenicline or the nicotine patch can help people with different types of emotion and attention levels to quit smoking.
Timeline
- Start
- 2015-12-14
- Primary completion
- 2028-02-28
- Completion
- 2028-02-28
Publications
- Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
- Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. doi: 10.1002/14651858.CD006219.pub4.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotine Patch | Unknown | 21 mg | Topical |
| Subject | Varenicline | Small molecule | 1 mg | Oral |